Adam S. Grossman
2023
In 2023, Adam S. Grossman earned a total compensation of $6M as Director, President, Chief Executive Officer and Interim Chief Financial Officer at ADMA Biologics, a 128% increase compared to previous year.
Compensation breakdown
| Bonus | $793,125 |
|---|---|
| Option Awards | $2,527,844 |
| Salary | $750,000 |
| Stock Awards | $1,921,878 |
| Other | $46,802 |
| Total | $6,039,649 |
Grossman received $2.5M in option awards, accounting for 42% of the total pay in 2023.
Grossman also received $793.1K in bonus, $750K in salary, $1.9M in stock awards and $46.8K in other compensation.
Rankings
In 2023, Adam S. Grossman's compensation ranked 72nd out of 2,218 executives tracked by ExecPay. In other words, Grossman earned more than 96.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 72 out of 2,218 | 97th |
Division Manufacturing | 37 out of 1,200 | 97th |
Major group Chemicals And Allied Products | 27 out of 673 | 96th |
Industry group Drugs | 26 out of 644 | 96th |
Industry Biological Products, Except Diagnostic Substances | 8 out of 156 | 95th |
Source: SEC filing on April 15, 2024.
Grossman's colleagues
We found one more compensation record of an executive who worked with Adam S. Grossman at ADMA Biologics in 2023.
2023
Brian Lenz
ADMA Biologics
Chief Financial Officer
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019